IL TUO ORDINE
Il tuo carrello è vuoto
Inizia ad aggiungere peptidi da ricerca al tuo carrello.
POTREBBE PIACERTI ANCHE
Il tuo carrello è vuoto
Inizia ad aggiungere peptidi da ricerca al tuo carrello.
POTREBBE PIACERTI ANCHE
NewPeptide PenTriple Receptor Research Peptide
Free shipping over 161,00 € · ships within 24h
FIDATO DAI RICERCATORI
Triple-Receptor Action
GLP-1 + GIP + glucagon — the only peptide engaging all three incretin pathways for next-generation metabolic research
Most-Studied Tri-Incretin
Same compound from Eli Lilly's TRIUMPH phase-2 programme reporting record-breaking results
Full Titration Range
Adjustable pen dial covers 0.5 mg → 12 mg weekly without product waste
Once-Weekly Convenience
6-day half-life allows simple weekly dosing schedule
A triple receptor agonist (GLP-1 / GIP / Glucagon) investigated in early-phase metabolic research. Studies suggest Retatrutide may modulate appetite, glucose homeostasis, and energy expenditure through three independent incretin pathways. ORYN Retatrutide delivers 5mg/3ml in a reusable pen system with precision dosing for 30 days.
LEARN ABOUT THE RETATRUTIDE PEN FORMAT →GLP-1 + GIP + glucagon — the only peptide engaging all three incretin pathways for next-generation metabolic research
Same compound from Eli Lilly's TRIUMPH phase-2 programme reporting record-breaking results
Adjustable pen dial covers 0.5 mg → 12 mg weekly without product waste
6-day half-life allows simple weekly dosing schedule
Acqua batteriostatica, siringa, miscelazione precisa
Le tacche della siringa possono variare del 10-20%
Tappo in gomma perforato più volte
La potenza diminuisce dopo la ricostituzione
5-10 minuti per preparazione
Fiale, siringhe, acqua, aghi...
Retatrutide research uses fine-grained weekly dose escalations (0.5 mg → 12 mg). The pen's adjustable dial covers the entire phase-2 range without product waste.
Triple-receptor agonists are structurally complex. The sealed pen cartridge protects the molecule from the reconstitution and oxidative steps that can degrade its tri-receptor activity.
Phase-2 protocols run 24-48 weeks. The pen format guarantees that dose 1 and dose 30 deliver the same molecule at the same purity — critical for longitudinal research data.
5 mg in one pen covers a full 30-day dose-escalation block, simplifying procurement for multi-month research programs.
Tempo di Prep.
Precisione Dose
Sterilità
Stabilità
Attach needle and prime with small test dose
Dial the prescribed weekly dose
Inject subcutaneously in the abdomen, thigh, or upper arm
Administer on the same day each week
Hold 10 seconds before removing to ensure full delivery
Rotate injection sites weekly
Utilizzare sempre un ago sterile nuovo per ogni somministrazione. Smaltire gli aghi usati in un apposito contenitore per taglienti. Conservare la penna in frigorifero a 2-8°C.
Triple GLP-1 / GIP / Glucagon Receptor Agonist
4,731.27 g/mol
Approximately 6 days
Retatrutide is the most extensively studied tri-incretin compound to date. It activates GLP-1, GIP, and glucagon receptors simultaneously — adding a glucagon-receptor arm to the dual mechanism of Tirzepatide. Early-phase research suggests this triple action may modulate appetite, glucose homeostasis, and energy expenditure through three independent incretin pathways at once.
First-in-human data confirmed safe activation of all three incretin receptors with dose-dependent metabolic responses.
Reported up to 24% body weight reduction at 48 weeks — the largest effect size observed for any incretin compound to date.
Significant reductions in liver fat content observed in metabolic dysfunction-associated steatotic liver research.
“Retatrutide's triple-receptor mechanism is a real step beyond Tirzepatide. The ORYN pen lets us run the full phase-2 escalation without juggling vials and dilutions.”
Dr. S. Hoffmann
Metabolic Research, Frankfurt
“Independent HPLC confirmed >99.3% purity on our first batch. The pen format makes the long titration window genuinely manageable for multi-month studies.”
Dr. T. Nilsson
Diabetes Research, Uppsala
“GLP-1 + GIP + glucagon all in one molecule, in a pen format that doesn't require redilution between weekly doses. Exactly what tri-incretin research needs.”
Dr. A. Dupont
Endocrinology Lab, Paris
Retatrutide is a triple agonist (GLP-1 + GIP + glucagon receptors) while Tirzepatide is dual (GLP-1 + GIP). Adding glucagon-receptor activation may further increase energy expenditure and lipid mobilisation. Phase-2 trials reported up to 24% body weight reduction vs Tirzepatide's ~22.5%.
Unisciti a oltre 3.000 ricercatori. SOP mensili, lanci di nuovi peptidi e un codice WELCOME10 per il tuo primo ordine.
NO SPAM · UNSUBSCRIBE ANYTIME
COA incluso con ogni ordine. Report specifici per lotto disponibili su richiesta.
See how ORYN pre-mixed peptide pens compare to traditional vials and other suppliers.
| Feature | ORYN Pens | Traditional Vials | Other Suppliers |
|---|---|---|---|
| Format | Pre-mixed pen | Lyophilised powder | Mixed |
| Purity | >99% verified | Variable (70-95%) | Claims vary |
| Dosing accuracy | <2% error | ~15% error | N/A |
| Reconstitution needed | No | Yes | Sometimes |
| Contamination risk | Sealed system | Multi-use vial | Varies |
| COA included | Every order | Rarely | Sometimes |
| GMP certified | Yes | Rarely | Some |
| EU customs-free | Yes | Often no | Varies |
Questo prodotto è destinato esclusivamente a scopi di laboratorio e ricerca. Non per consumo umano.
Sistema penna premium con dosaggio completamente regolabile. Prodotto GMP, purezza >99% garantita.
Più VendutoPeptide PenBPC-157Peptide di Ricerca per la Rigenerazione
Peptide PenTB-500Peptide di Ricerca per la Migrazione Cellulare
Peptide PenCJC-1295Peptide di Ricerca Secretagogo del GH
Legal under MHRA rules. BPC-157, tirzepatide & NAD+ pens with next-day UK delivery from £99. >99% purity, GMP certified. Shop now.
ARTICLEPens cut dosing error from 15% to under 2%. We compare accuracy, contamination risk, cost, and convenience. See why researchers are switching in 2026.
ARTICLEOver 100 published studies back BPC-157 for tissue repair, gut healing, and neuroprotection. Mechanisms, dosing protocols, and where to buy in the UK.
COMPARISONConfronta BPC-157 e TB-500 per la ricerca sul recupero. Meccanismi, benefici, dosaggio e quando usare ogni peptide. Acquista entrambi come penne premiscelate.
COMPARISONConfronta tirzepatide e semaglutide per la ricerca metabolica. Recettore doppio vs singolo, dati di efficacia, effetti collaterali e prezzi. Acquista penne tirzepatide.
ENCYCLOPEDIATriple Hormone Receptor Agonist (GIP/GLP-1/Glucagon). Peso molecolare: 4611.09 Da. Esplora il meccanismo d'azione, studi chiave e applicazioni di ricerca.
BUNDLEIl classico duo di guarigione per una riparazione tissutale accelerata
PROTOCOLProtocollo di ricerca che combina le penne peptidiche BPC-157 e TB-500 per un recupero tissutale accelerato. Esplora i meccanismi di guarigione sinergici, i programmi di dosaggio e i risultati degli studi pubblicati.
FAQTutto sui sistemi di penne peptidiche. Come funzionano, vantaggi sui flaconcini e meccanismi di dosaggio.
CATEGORYResearch-grade recovery peptide pens. BPC-157 and TB-500 for tissue repair, wound healing, and inflammation research. >99% purity, UK delivery.
CATEGORYResearch-grade weight loss peptide pens. Tirzepatide dual GIP/GLP-1 agonist for metabolic research. Pre-mixed pens, >99% purity, next-day UK delivery.
